Add BrightSurf on Google Email

New study explains why we may feel the cold more as we age

A new study reveals that the decline in thermogenic fat activity with age may explain why older people feel the cold more. The research suggests that restoring thermogenic fat activity could help understand and treat age-related metabolic problems, including obesity and type 2 diabetes.

SourceCity of Hope·JournalNature·TypeExperimental study·DateNov 11, 2026

Chinese Medical Journal article review explores AI-powered CGM data analysis in diabetes care

Researchers review how AI enhances continuous glucose monitoring to enable predictive, personalized diabetes management, improving glycemic outcomes and prioritizing high-risk patients. Machine learning models forecast individualized responses to meals, enabling tailored dietary and physical activity guidance.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeCommentary/editorial·DateNov 6, 2026

Earlier bedtime linked to weight loss in prediabetes

A randomized controlled trial found that adding sleep coaching to a diabetes prevention lifestyle program helped participants sleep better and feel less sleepy during the day, leading to greater weight loss. Falling asleep earlier was associated with about 1.3 pounds of weight loss over eight weeks, independent of sleep duration.

SourceNew York University·JournalNursing Research·DateNov 2, 2026

Endocrinologists who demonstrate greater medical knowledge more likely to prescribe a recommended treatment for patients with type 2 diabetes

A study found that endocrinologists who scored higher on the American Board of Internal Medicine's Longitudinal Knowledge Assessment were more likely to prescribe key diabetes drug classes following a treatment guidelines update. The study analyzed Medicare claims data from 2017 to 2022 and included 1,061 endocrinologists caring for 17...

SourceAmerican Board of Internal Medicine·JournalJAMA Network Open·TypeObservational study·DateOct 27, 2026

Scientists see new vocal patterns associated with type 2 diabetes

A new study by Klick Labs reveals complex patterns in voice recordings that are associated with Type 2 diabetes. The research used 14,759 voice recordings from 461 adults, analyzing spectrograms and identifying acoustic patterns related to diabetes. The study achieved balanced accuracy of 71.3 percent for women and 72.4 percent for men.

SourceKlick Applied Sciences·JournalIEEE Journal of Biomedical and Health Informatics·TypeData/statistical analysis·DateOct 19, 2026

Longer sleep may be linked to a higher risk of kidney disease in people with type 2 diabetes

A study published in the Journal of the Endocrine Society found that people with type 2 diabetes who sleep longer may be at a higher risk of developing or worsening diabetic kidney disease. Longer sleep duration was particularly associated with an increased risk among older adults and those with existing kidney damage.

SourceThe Endocrine Society·JournalJournal of the Endocrine Society·DateOct 8, 2026

A low-fat vegan diet cuts liver fat by a third and improves insulin function in adults with type 2 diabetes, finds new study

A new 16-week clinical trial found that a low-fat vegan diet reduced liver fat by a third and improved insulin function in adults with type 2 diabetes. The study, which measured liver fat, muscle fat, visceral fat, and tissue AGE accumulation, showed that healthy eating can reverse underlying mechanisms driving the disease.

SourcePhysicians Committee for Responsible Medicine·JournalBMJ Open Diabetes Research & Care·TypeRandomized controlled/clinical trial·DateOct 8, 2026

Pregnancy complications linked to higher risk of cardiac and renal health conditions

A UK study found that women with pregnancy complications, including gestational diabetes and high blood pressure, face an elevated risk of developing cardiometabolic-renal conditions in subsequent years. The study, which followed over 1.4 million women, identified associations between postnatal depression and an increased risk of four ...

SourceBMJ Group·JournalBMJ Medicine·TypeObservational study·DateOct 6, 2026

Clinical trial provides preliminary evidence of blood-pressure effect from feijoa

A clinical trial found that feijoa powder improved systolic blood pressure in people with prediabetes, which was an unexpected finding in a study designed to test its effects on weight loss and blood sugar control. Larger trials are needed to confirm these results and fully understand the potential benefits of feijoa powder.

SourceUniversity of Auckland·JournalDiabetes Obesity and Metabolism·TypeRandomized controlled/clinical trial·DateSep 30, 2026

Mauritius is the first country to show it is reversing the type 2 diabetes epidemic using gold standard testing across four decades

Mauritius has systematically monitored type 2 diabetes using the 2-hour oral glucose tolerance test, showing a 61% increase in prevalence between 1987 and 2009, but a 11% decrease between 2009 and 2021. The country's multisectoral approaches to prevention and management may hold the key to reversing the epidemic, according to the study.

SourceEuropean Association for the Study of Diabetes·JournalThe Lancet Diabetes & Endocrinology·DateSep 30, 2026

Study shows low energy diet combined with structured exercise reverses early onset type 2 diabetes in half of participants

Researchers found that a low-energy diet combined with structured exercise can reverse early onset type 2 diabetes in approximately half of participants. The study, which included 96 participants aged 18-45, showed significant improvements in blood sugar control, fitness, and muscle mass.

SourceEuropean Association for the Study of Diabetes·JournalThe Lancet Regional Health - Americas·DateSep 30, 2026

New investigational drug combining eloralintide and tirzepatide (EloraTZP) led to weight loss of up to 23.3% in people living with obesity and type 2 diabetes

The phase 2b study evaluates the safety and efficacy of eloralintide in combination with tirzepatide, resulting in substantial weight loss and improvements in blood sugar control. The study demonstrated substantial weight loss and reduction in glycated haemoglobin (HbA1c) across different dosing combinations.

New daily orforglipron pill demonstrated cardiovascular safety in its largest and longest study of type 2 diabetes (ACHIEVE-4 study)

The ACHIEVE-4 study shows orforglipron pills offer superior weight loss and blood sugar control compared to insulin glargine, but with a higher gastrointestinal adverse event rate. Non-inferiority for cardiovascular safety and superiority for weight reduction were demonstrated.

Novo Nordisk Foundation renews commitment to investigate genomic mechanisms of disease at Broad Institute in collaboration with Danish scientists

The Novo Nordisk Foundation has renewed its $53 million commitment to the Broad Institute's Center for Genomic Mechanisms of Disease. This funding will accelerate research into the genetic and biological mechanisms underlying type 2 diabetes and obesity, with the goal of identifying new therapeutic targets. The center will expand on it...

Women are and will be the predominant users of GLP-1 receptor agonists (GLP-1 RAs) in future – but much work still needed to analyse specific effects of these drugs in women and address equality in access globally

Women are more likely to experience weight loss and improved blood sugar control with GLP-1 RAs, but face higher rates of side effects and unequal access to treatment worldwide. Extensive research is needed to address these disparities and optimize treatment for women in various domains.

SourceEuropean Association for the Study of Diabetes·JournalThe Lancet Obstetrics, Gynaecology, & Women’s Health·DateSep 29, 2026

New triple agonist retatrutide produces substantial weight loss and improvements in blood sugar control in people living with obesity and type 2 diabetes – TRIUMPH-2 study

Retatrutide demonstrates substantial weight loss and improved blood sugar control in adults with overweight and type 2 diabetes, with 47% of participants losing at least 20% of their starting weight. The treatment also improves cardiometabolic risk factors and reduces inflammation.

Reducing ultra-processed food (UPF) intake and being physically active can cut risk of type 2 diabetes, regardless of genetic make-up

A new study suggests that eating a diet low in ultra-processed foods and exercising regularly can reduce the risk of type 2 diabetes, even in those with a strong genetic predisposition. The analysis of data on tens of thousands of people found that those who followed these habits were up to 70% less likely to develop the condition.

High prevalence of neurodiversity among young people diagnosed with type 2 diabetes, suggests study of over 6 million people

A study of over 6 million people found that individuals diagnosed with type 2 diabetes before the age of 20 were more likely to have ADHD (14%) and autism (5.7%) compared to those without T2D. This suggests that healthcare systems may need to consider the needs of neurodivergent people when providing care for early-onset T2D.

Study examines racial disparities in patients’ adherence to their diabetes medications

A new study published in JAMA Network Open found that Black and Hispanic patients are less likely to adhere to their diabetes medications compared to White patients. The study, which analyzed national health data from 2019, showed that extra assistance programs significantly reduced treatment gaps, particularly for high-cost treatments.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Network Open·TypeData/statistical analysis·DateSep 23, 2026

Cancer incidence remains higher in people with type 2 diabetes, with the gap widening in recent years

A nationwide study in Denmark found that cancer incidence is 12% higher among men with type 2 diabetes and 22% higher among women with type 2 diabetes compared to those without diabetes. Obesity-related cancers, such as colorectal and postmenopausal breast cancer, are particularly prevalent among people with type 2 diabetes.

Regular exercise has greater impact on reducing risk of type 2 diabetes in younger adults, but the highest absolute benefit in older adults, finds UK Biobank study

A UK Biobank study found that higher levels of moderate-to-vigorous physical activity are associated with a substantially lower risk of developing type 2 diabetes, particularly among younger adults. Encouraging older adults to be physically active could prevent more cases of type 2 diabetes due to their high overall risk.

SourceEuropean Association for the Study of Diabetes·JournalDiabetes Obesity and Metabolism·DateSep 17, 2026

Pennington Biomedical researchers help advance new tool for analyzing continuous glucose monitoring data

Researchers at Pennington Biomedical developed GVC-Calc to analyze continuous glucose monitoring data, providing a scalable and transparent approach. The platform supports batch processing, integrates individual-level data with cohort-level results, and offers consensus clinical metrics alongside exploratory measures.

SourcePennington Biomedical Research Center·JournalNature Metabolism·TypeCommentary/editorial·DateSep 16, 2026

The European Association for the Study of Diabetes publishes its first-ever clinical guideline and the world's first to focus on diabetes distress

The EASD has published its first evidence-based clinical practice guideline on diabetes distress, emphasizing the importance of assessing and managing emotional burdens in adults with type 1 and type 2 diabetes. The guideline aims to improve clinical care and outcomes by incorporating a person-centered approach to diabetes care.

SourceEuropean Association for the Study of Diabetes·JournalDiabetologia·TypeSystematic review·DateSep 16, 2026

Study shows link between more severe and much earlier development of type 2 diabetes in women who had gestational diabetes in pregnancy

Women with a history of gestational diabetes in pregnancy are at a substantially increased risk of developing type 2 diabetes later in life, with a median onset age 13 years earlier than those without prior gestational diabetes. They also experience more severe disease, requiring insulin treatment more frequently.

Three distinct BMI trajectories identified in people with type 2 diabetes

A recent study identified three distinct BMI trajectories among people with type 2 diabetes, with stable, increasing, and decreasing trajectories associated with different comorbidities and healthcare service use. Increasing BMI was linked to a clustering of chronic diseases, while weight loss was not always indicative of better health...

SourceUniversity of Eastern Finland·JournalDiabetes Research and Clinical Practice·DateSep 1, 2026

Tiny toxic protein clumps may hold the key to developing early diagnosis and new therapies for protein-misfolding diseases like Alzheimer’s

Researchers suggest that targeting tiny protein aggregates known as oligomers, which form early in the disease process, may lead to breakthroughs in treating protein-misfolding diseases. Oligomers are increasingly believed to drive cellular damage, and their early formation may be more toxic than large protein deposits.

SourceUniversity of Southern Denmark·JournalNature Reviews Chemistry·TypeSystematic review·DateAug 21, 2026

Muscle-boosting molecule released during exercise

A key molecule released during exercise, L-β-aminoisobutyric acid (L-BAIBA), has been discovered to strengthen muscles, improve exercise performance, and protect against muscle damage in type 2 diabetes. The study reveals L-BAIBA's role in muscle adaptation, metabolism, and contraction, offering promising insights for future therapies.

SourceUniversity of Leeds·JournalNature Communications·DateAug 18, 2026